Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach.
Since the prioritization of Lymphatic Filariasis (LF) elimination in 1997, progress has been made in reducing disease transmission and burden. Validation of elimination through Transmission Assessment Surveys (TAS) in implementation units (IUs) that have received at least 5 rounds of mass drug admin...
Main Authors: | Doris W Njomo, Lydiah W Kibe, Bridget W Kimani, Collins Okoyo, Wyckliff P Omondi, Hadley M Sultani |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-09-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | https://doi.org/10.1371/journal.pntd.0008499 |
Similar Items
-
Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach
by: Doris W. Njomo, et al.
Published: (2020-09-01) -
Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
by: Doris W Njomo, et al.
Published: (2020-12-01) -
The role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in Kenya.
by: Doris W Njomo, et al.
Published: (2012-01-01) -
Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021-03-01) -
Increasing coverage in mass drug administration for lymphatic filariasis elimination in an urban setting: a study of Malindi Town, Kenya.
by: Doris W Njomo, et al.
Published: (2014-01-01)